Washington DC-Baltimore Area
With 28+ years in the pharmaceutical industry, I am an accomplished oncology therapeutic specialist with a proven track record of driving product adoption, building strong partnerships with healthcare providers, and improving patient access to innovative therapies. My experience spans cardiovascular, virology, and oncology, where I have successfully supported multiple product launches, including immunotherapies and targeted therapies. I currently focus on advancing treatment options for metastatic pancreatic ductal adenocarcinoma (mPDAC) and GEP-NET. Known for my collaborative approach, I work closely with cross-functional matrix teams, oncologists, nurses, pharmacists, and advanced practice providers to support optimal patient care and ensure the safe and effective use of complex oncology therapies. I am passionate about translating clinical data into meaningful insights that help healthcare teams make informed treatment decisions. I am also a strong advocate for health equity in oncology. As a co-leader of the PAN (PBRG) Global Health Equity Team, I collaborate with partners such as Gryt Health on the Diversity in Oncology platform, helping amplify the voices and lived experiences of underserved patients in cancer care and clinical trials. Throughout my career, I have been recognized with multiple awards for sales performance, leadership, and commitment to inclusion and patient advocacy. I am also passionate about mentorship and have contributed to brand strategy, patient education initiatives, advocacy programs, and innovative technologies that support the oncology community. Outside of work, I enjoy traveling, cycling, golfing with friends, and discovering great food and wine—experiences that keep me curious, balanced, and energized.
I am thrilled to share that I have joined Ipsen Biopharmaceuticals as Senior Oncology Account Specialist. This opportunity marks a significant milestone in my career, and I am eager to start helping patients and customers as part of the Midatlantic Middies at Ipsen. I want to extend my heartfelt gratitude to my colleagues and mentors at BMS for their support and guidance over the years. Your encouragement has been invaluable, and I look forward to applying the skills and experiences I've gained to my new role. #NewBeginnings #CareerGrowth
* Leadership & Professional Contributions • Co-Lead, BMS PAN Global Health Equity Team • Co-Lead, Diversity in Oncology initiative in collaboration with external partners • Member, Sales Leadership Society (SLS), 2016–2023 * Awards & Recognition • District Leadership Award: 1999, 2003, 2004, 2009–2011, 2013–2016 • Top 15% of Sales Performance: 1998, 1999, 2002, 2006, 2009, 2012, 2013, 2015–2017 • Best Performer: 1998, 1999, 2002, 2009 • Customer Focus Award: 2000 • Vision Award for Competitiveness: 2002 • Best Supporting Role, Acting Cardiovascular Specialist District Manager: 2003 • BMS Bio-Pharma Behavior Winner: 2011, 2018 • Oncology Peer Choice Award: 2020 • Oncology Inclusion Winner: 2021 • PBRG PAN Impact Award: 2021, 2023 * Additional Leadership & Strategic Contributions • Supported multiple successful product launches across therapeutic areas • Provided sales leadership and strategic field insight for brand initiatives • Led and contributed to diversity, inclusion, and health equity initiatives • Served as brand point, business acumen point, technology point, and process improvement lead • Mentored colleagues and supported sales training and professional development • Participated in Hepatitis Council initiatives • Served as Acting District Business Manager, supporting team leadership and district operations
Promoted entecavir for the treatment of hepatitis B to physicians across community practices and academic medical centers. Partnered with primary care providers to increase awareness of hepatitis B, supporting patient education on disease management and available treatment options. Engaged with local communities through health fairs and outreach initiatives to improve understanding of hepatitis B and encourage proactive care.
Promoted antiplatelet, antithrombotic, and antihypertensive therapies to cardiologists and key healthcare providers across community practices and academic medical centers. Built strong clinical relationships by translating complex clinical data into meaningful insights that supported evidence-based treatment decisions in cardiovascular care. Collaborated with cross-functional matrix teams—including marketing, medical affairs, and market access—to successfully support the launch of two cardiovascular products. Contributed field insights to help inform brand strategy, identify opportunities for practice engagement, and ensure effective product adoption within the cardiovascular community.